[HTML][HTML] What is known about breast cancer in young women?
Simple Summary Breast cancer is the most common cancer affecting women under 40 years
of age worldwide, with an increasing number of cases diagnosed each year. Despite this …
of age worldwide, with an increasing number of cases diagnosed each year. Despite this …
Recent advances in nanoparticle-based cancer treatment: a review
The advent and subsequent development of nanotechnology in the past few years have
been a boon to the healthcare industry and especially in cancer therapy. Cancer, as it is …
been a boon to the healthcare industry and especially in cancer therapy. Cancer, as it is …
Breast cancer genetics in young women: What do we know?
L Gómez-Flores-Ramos, RM Álvarez-Gómez… - … Research/Reviews in …, 2017 - Elsevier
Breast cancer (BC) in young women, generally defined in oncology as women who are 40
years of age or younger, represents 2 out of 10 BC cases in developing countries. Several …
years of age or younger, represents 2 out of 10 BC cases in developing countries. Several …
[HTML][HTML] Exploring Potentilla nepalensis Phytoconstituents: Integrated Strategies of Network Pharmacology, Molecular Docking, Dynamic Simulations, and MMGBSA …
Potentilla nepalensis belongs to the Rosaceae family and has numerous therapeutic
applications as potent plant-based medicine. Forty phytoconstituents (PCs) from the root and …
applications as potent plant-based medicine. Forty phytoconstituents (PCs) from the root and …
Comparison of patient susceptibility genes across breast cancer: implications for prognosis and therapeutic outcomes
S Peleg Hasson, T Menes… - Pharmacogenomics and …, 2020 - Taylor & Francis
Hereditary breast cancer syndromes affect a small (10–15% of cases) but significant group
of patients. BRCA1 and BRCA2 are the most familiar and well-studied genes associated …
of patients. BRCA1 and BRCA2 are the most familiar and well-studied genes associated …
[HTML][HTML] p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies
B Diakite, Y Kassogue, G Dolo, J Wang… - BMC Medical …, 2020 - Springer
Background The effect of the p. Arg72Pro variant of the P53 gene on the risk of development
ofbreast cancer remains variable in populations. However, the use ofstrategies such …
ofbreast cancer remains variable in populations. However, the use ofstrategies such …
Introduction of mutant TP53 related genes in metabolic pathways and evaluation their correlation with immune cells, drug resistance and sensitivity
Background Although the relationship between TP53 mutation, TP53 metabolism pathways,
and tumorigenesis has been investigated, pan-cancer analysis of TP53 mutations and …
and tumorigenesis has been investigated, pan-cancer analysis of TP53 mutations and …
Breast cancer in patients with Li–Fraumeni syndrome–a case-series study and review of literature
AG Nandikolla, S Venugopal… - Breast Cancer: Targets …, 2017 - Taylor & Francis
Background Li–Fraumeni Syndrome (LFS) is a rare disease with autosomal dominant
inheritance linked to germline mutations of tumor suppressor gene TP53. These patients are …
inheritance linked to germline mutations of tumor suppressor gene TP53. These patients are …
[HTML][HTML] Molecular biology in young women with breast cancer: From tumor gene expression to DNA mutations
L Gómez-Flores-Ramos… - Revista de …, 2017 - medigraphic.com
Young women with breast cancer (YWBC) represent roughly 15% of breast cancer (BC)
cases in Latin America and other developing regions. Breast tumors occurring at an early …
cases in Latin America and other developing regions. Breast tumors occurring at an early …
Clinical contribution of next-generation sequencing multigene panel testing for BRCA negative high-risk patients with breast cancer
Background Breast cancer is the most common malignancy in women and thought to be
hereditary in 10% of patients. Recent next-generation sequencing studies have increased …
hereditary in 10% of patients. Recent next-generation sequencing studies have increased …